Inhibition of mammary gland tumors by short-term treatment of estradiol-3-benzoate associated with down-regulation of estrogen receptor ERα and ERβ

Oncology Reports

Volumn 12, Issue 4, 2004, Pages 689-693

  Kang, Jin Seok ^a,c   Kim, Seyl ^a   Che, Jeong Hwan ^a   Nam, Ki Taek ^a   Kim, Dae Joong ^b   Jang, Dong Deuk ^a   Yang, Ki Hwa ^a  

^a Korea Food and Drug Administration   (South Korea)

^b Chungbuk National University   (South Korea)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

7,12 dimethylbenz a anthracene; Estradiol 3 benzoate; Estrogen receptor alpha; Estrogen receptor beta; Mammary gland tumor; N methyl N nitrosourea

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ALKYLATING AGENT; CARCINOGEN; DRUG DERIVATIVE; ESTRADIOL; ESTRADIOL 3-BENZOATE; ESTRADIOL BENZOATE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; METHYLNITROSOUREA;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; CHEMICALLY INDUCED DISORDER; DOWN REGULATION; DRUG EFFECT; EXPERIMENTAL NEOPLASM; FEMALE; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; UDDER;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ALKYLATING AGENTS; ANIMALS; CARCINOGENS; CELL DIFFERENTIATION; DOWN-REGULATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; RATS; RATS, SPRAGUE-DAWLEY;

EID: 16644374773     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.12.4.689     Document Type: Article

References (41)

1. Key TJ and Pike MC: The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24: 29-43, 1988. (Pubitemid 18009332)
2. Bergkvist L, Adami HO, Persson I, Hoover R and Schairer C: The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 321: 293-297, 1989. (Pubitemid 19193804)
3. Bernstein L and Ross RK: Endogenous hormones and breast cancer risk. Epidemiol Rev 15: 48-65, 1993. (Pubitemid 23269070)
4. Pike MC, Krailo MD, Henderson BE, Casagrande JT and Hoel DG: 'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature 303: 767-770, 1983. (Pubitemid 13054488)
5. Nandi S, Guzman RC and Yang J: Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc Natl Acad Sci USA 92: 3650-3657, 1995.
6. Migliaccio A, Pagano M and Auricchio F: Immediate and transient stimulation of protein tyrosine phosphorylation by estradiol in MCF-7 cells. Oncogene 8: 2183-2191, 1993. (Pubitemid 23226952)
7. Ueda M, Takagi H, Onodera H, Yasuhara K, Takizawa T, Imai T, Mitsumori K, Matsui T and Hirose M: Enhancing effects of beta-estradiol 3-benzoate but not methoxychlor on the promotion/progression stage of chemically-induced mammary carcinogenesis in ovariectomized rats. Jpn J Cancer Res 93: 752-759, 2002.
8. Sutherland RL, Prall OW, Watts CK and Musgrove EA: Estrogen and progestin regulation of cell cycle progression. J Mammary Gland Biol Neoplasia 3: 63-72, 1998. (Pubitemid 128513220)
9. Barlow J, Casey T, Chiu JF and Plaut K: Estrogen affects development of alveolar structures in whole-organ culture of mouse mammary glands. Biochem Biophys Res Commun 232: 340-344, 1997. (Pubitemid 27216215)
10. Hilakivi-Clarke L, Cho E, deAssis S, Olivo S, Ealley E, Bouker KB, Welch JN, Khan G, Clarke R and Cabanes A: Maternal and prepubertal diet, mammary development and breast cancer risk. J Nutr 131: S154-S157, 2001.
11. Yuan JM, Yu MC, Ross RK, Gao YT and Henderson BE: Risk factors for breast cancer in Chinese women in Shanghai. Cancer Res 48: 1949-1953, 1988.
12. Guzman RC, Yang J, Rajkumar L, Thordarson G, Chen X and Nandi S: Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc Natl Acad Sci USA 96: 2520-2525, 1999. (Pubitemid 29117948)
13. Rajkumar L, Guzman RC, Yang J, Thordarson G, Talamantes F and Nandi S: Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis. Proc Natl Acad Sci USA 98: 11755-11759, 2001. (Pubitemid 32928801)
14. Hilakivi-Clarke L, Cabanes A, Olivo S, Kerr L, Bouker KB and Clarke R: Do estrogens always increase breast cancer risk? J Steroid Biochem Mol Biol 80: 163-174, 2002. (Pubitemid 34233738)
15. Russo J and Russo IH: Experimentally induced mammary tumors in rats. Breast Cancer Res Treat 39: 7-20, 1996. (Pubitemid 26136500)
16. Korach KS, Couse JF, Curtis SW, Washburn TF, Lindzey J, Kimbro KS, Eddy EM, Migliaccio S, Snedeker SM, Lubahn DB, Schomberg DW and Smith EP: Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Prog Horm Res 51: 159-186, 1996. (Pubitemid 126476613)
17. Saji S, Jensen EV, Nilsson S, Rylander T, Warner M and Gustafsson JA: Estrogen receptors alpha and beta in the rodent mammary gland. Proc Natl Acad Sci USA 97: 337-342, 2000. (Pubitemid 30055832)
18. Leygue E, Dotzlaw H, Watson PH and Murphy LC: Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis. Cancer Res 58: 3197-3201, 1998. (Pubitemid 28371051)
19. Roger P, Sahla ME, Makela S, Gustafsson JA, Baldet P and Rochefort H: Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res 61: 2537-2541, 2001. (Pubitemid 32685835)
20. Lazennec G, Bresson D, Lucas A, Chauveau C and Vignon F: ER beta inhibits proliferation and invasion of breast cancer cells. Endocrinology 142: 4120-4130, 2001. (Pubitemid 32802685)
21. Son HY, Nishikawa A, Ikeda T, Furukawa F and Hirose M: Lack of modification by environmental estrogenic compounds of thyroid carcinogenesis in ovariectomized rats pretreated with N-bis(2-hydroxypropyl)nitrosamine (DHPN). Jpn J Cancer Res 91: 966-972, 2000.
22. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR and van Zwieten MJ: Comparative study of human and rat mammary tumorigenesis. Lab Invest 62: 244-278, 1990. (Pubitemid 20124262)
23. Shan L, He M, Yu M, Qiu C, Lee NH, Liu ET and Snyderwine EG: cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine and 7,12-dimethylbenz[a] anthracene. Carcinogenesis 23: 1561-1568, 2002. (Pubitemid 35214939)
24. Kuramoto T, Morimura K, Yamashita S, Okochi E, Watanabe N, Ohta T, Ohki M, Fukushima S, Sugimura T and Ushijima T: Etiology-specific gene expression profiles in rat mammary carcinomas. Cancer Res 62: 3592-3597, 2002. (Pubitemid 34728830)
25. Grubbs CJ, Peckham JC and McDonough KD: Effect of ovarian hormones on the induction of 1-methyl-1-nitrosourea-induced mammary cancer. Carcinogenesis 4: 495-497, 1983. (Pubitemid 13105332)
26. Medina D, Peterson LE, Moraes R and Gay J: Short-term exposure to estrogen and progesterone induces partial protection against N-nitroso-N-methylurea-induced mammary tumorigenesis in Wistar-Furth rats. Cancer Lett 169: 1-6, 2001. (Pubitemid 32532089)
27. Li S, Martel C, Dauvois S, Belanger A and Labrie F: Effect of estrone on the growth of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in the rat: a model of postmenopausal breast cancer. Endocrinology 134: 1352-1357, 1994. (Pubitemid 24085590)
28. Bigsby RM: Synergistic tumor promoter effects of estrone and progesterone in methylnitrosourea-induced rat mammary cancer. Cancer Lett 179: 113-119, 2002.
29. Liehr JG: Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev 21: 40-54, 2000.
30. Yang X, Edgerton SM, Kosanke SD, Mason TL, Alvarez KM, Liu N, Chatterton RT, Liu B, Wang Q, Kim A, Murthy S and Thor AD: Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice. Cancer Res 63: 2425-2433, 2003. (Pubitemid 36605179)
31. Menard S, Aiello P, Tagliabue E, Rumio C, Lollini PL, Colnaghi MI and Balsari A: Tamoxifen chemoprevention of a hormone-independent tumor in the proto-neu transgenic mice model. Cancer Res 60: 273-275, 2000. (Pubitemid 30070750)
32. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P and Chambon P: Human oestrogen receptor cDNA: sequence, expression and homology to v- erb-A. Nature 320: 134-139, 1986. (Pubitemid 16105150)
33. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S and Gustafsson JA: Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93: 5925-5930, 1996. (Pubitemid 26190778)
34. Pettersson K, Delaunay F and Gustafsson JA: Estrogen receptor beta acts as a dominant regulator of estrogen signaling. Oncogene 19: 4970-4978, 2000.
35. Kraichely DM, Sun J, Katzenellenbogen JA and Katzenellenbogen BS: Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members. Endocrinology 141: 3534-3545, 2000.
36. Dotzlaw H, Leygue E, Watson PH and Murphy LC: Expression of estrogen receptor-beta in human breast tumors. J Clin Endocrinol Metab 82: 2371-2374, 1997. (Pubitemid 27287615)
37. Vladusic EA, Hornby AE, Guerra-Vladusic FK, Lakins J and Lupu R: Expression and regulation of estrogen receptor beta in human breast tumors and cell lines. Oncol Rep 7: 157-167, 2000.
38. Jarvinen TA, Pelto-Huikko M, Holli K and Isola J: Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer. Am J Pathol 156: 29-35, 2000. (Pubitemid 30644435)
39. Omoto Y, Inoue S, Ogawa S, Toyama T, Yamashita H, Muramatsu M, Kobayashi S and Iwase H: Clinical value of the wild-type estrogen receptor beta expression in breast cancer. Cancer Lett 163: 207-212, 2001. (Pubitemid 32126367)
40. Speirs V, Parkes AT, Kerin MJ, Walton DS, Carleton PJ, Fox JN and Atkin SL: Coexpression of estrogen receptor alpha and beta: poor prognostic factors in human breast cancer? Cancer Res 59: 525-528, 1999. (Pubitemid 29076043)
41. Speirs V and Kerin MJ: Prognostic significance of oestrogen receptor beta in breast cancer. Br J Surg 87: 405-409, 2000. (Pubitemid 30192946)